CitSciMedBlitz Recap and Results

Posted on by ginger

Hopefully, you'll all forgive us for the delay in announcing the results of #CitSciMedBlitz. Our partners at EyesOnAlz, Cochrane crowd, and ourselves were a little tired after the blitz and we gave ourselves a short break. Since the blitz, the EyesOnAlz team has generated the #CitSciMedBlitz digital badge for participants of all three challenges and has been working on creating the trophies; meanwhile, the Cochrane crowd team has contacted the overall #CitSciMedBlitz event winners.

look alive now! We're all up and active now and looking forward to sharing a recap and the results of #CitSciMedBlitz with you.

First, a Recap

On February 21st, CitSciMedBlitz was kicked off with a webinar to introduce the three platforms that would be participating in CitSciMedBlitz
You can watch the webinar here

The first challenge, the StallCatchers challenge, was launched on February 26th at 7am PST. Within minutes of the launch, StallCatchers were hammering away at StallCatchers, including Cochrane Crowd's Anna.
first 10 min

Anna managed to get on the leaderboard but wasn't able to stay on there for very long because the competition was just too tough. At least she placed, though-- I never even made it!

By the end of the challenge, StallCatchers analyzed a whopping 18,348 real videos--the equivalent of two weeks worth of laboratory analysis!
first 10 min

While the EyesOnAlz team was still cooling off from their intense challenge, we were gearing up for the Mark2Cure arm--and NOT without a huge set of worries.
i am worried

You can read more about the hiccups and snafu's that happened during the Mark2Cure 24hr challenge here. By the end of the challenge, CitSciMedBlitzers managed to submit ~300 doc annotations, and ~3000 relationship annotations--an impressive feat considering the increase in task difficulty, and the bugs and other technical issues that made the challenge--well, even more challenging!

While we were busy analyzing the results of our challenge, Cochrane crowd was preparing the last challenge of CitSciMedBlitz. This challenge started off right with 50 assessments within the first 2 minutes, and over 5000 in just the first 4 hours! This arm of the challenge would determine which of the top contenders from the previous challenges would win the trophy so the competition was intense! By the end of this challenge, over 46,000 classifications would be made--allowing our teams to determine the overall winner of #CitSciMedBlitz.

And now...the results of CitSciMedBlitz...

Of course, the biggest winner of the challenge goes to...

...biomedical and health evidence research! Everyone who has contributed (in the past) and continues to contributes to these efforts deserve a round of applause for being generous enough to donate their time towards helping with disease and health research.

Thank you for being amazing

The winner of the CitSciMedBlitz trophy is Michael Landau! Note, it was previously stated that Michael was also the top contributor to the EyesOnAlz challenge of CitSciMedBlitz. This is wrong.

Mike Capraro was the top contributor across all three measures of the EyesOnAlz challenge and the overall top contributor of that challenge for CitSciMedBlitz.

Editor's note #2: If you'd like to read more about CitSciMedBlitz from the EyesOnAlz team, check out their latest recap post here!

The top contributor to the Mark2Cure arm of CitSciMedBlitz was Kien Pong Yap, while the top contributor to the Cochrane Crowd arm of CitSciMedBlitz was Nikolaos. The top contributors to each platform will be receiving a platform-specific trophy.

Each platform will be awarding additional prizes to some of their top contributors and the notifications should be arriving via email (if they haven't already).

Editor's note #3, the recap from the Cochrane Crowd side of things is now available

Now that all the excitement of CitSciMedBlitz is over, I'd like to thank ALL the citizen scientists who contribute to projects like ours and make these platforms great. In citizen science, the people make the platform. And, as you can see--the people contributing to these platforms, do so with:

a collaborative spirit,
sharing is caring

humor,
guilt to the rescue

humility,
struggled and won

good spirit,
positive attitude for the win

and grace,
positive attitude for the win

Thank you all! Much respect for the work that you've done and the character you've shown!

mad respects

Note this post was updated on 2018.03.12 to correct an error and on 2018.03.19 to add a link

CitSciMed Blitz has started!

Posted on by ginger

It's on! The CitSciMedblitz week of challenges have started!

If you missed the webinar detailing the three biomedical/health citizen science research projects, it is available for viewing on youtube.
CitSciMedblitz webinar

You are welcome to participate in as many or as few of the challenges as you'd like, but a trophy will be awarded to the highest ranking participant across all THREE challenges. Read more about CitSciMedblitz from this post at citscibio.org

With regards to the challenges, up first (and going on now!) is the EyesOnAlz 24hr Catchathon. EyesOnAlz is an Alzheimer disease-focused citizen science project investigating stalled blood in brain images. It has a lot of cool images/videos in need of review by citizen scientists and a lot of fun features. The challenge has only just started and will run to 7am PST (3pm GMT) tomorrow (Feb. 28th) so get in on it ASAP!

The Mark2Cure challenge will start at 7am PST (3pm GMT) on Wednesday, February 28th. It is a doubly-special day because the 28th is Rare Disease Day and we have had an incredibly inspirational weekend at the Sanford Burnham Presby Rare Disease Day Symposium. We look forward to sharing rare disease stories from Mark2Curators and bringing awareness about these diseases as we tackle the literature around NGLY1 during this 24hr challenge.

Speaking of literature, our old friends at Cochrane Crowd are back with a lot of new features which you can explore during the Cochrane Screening Challenge. This challenge starts at 7am PST (3pm GMT) on Friday, March 2nd and runs for 24hrs.

CitSciMed Blitz, Rare Disease Day, and more

Posted on by ginger

It's finally February which means it's time to prepare for Rare Disease Day 2018 and CitSciMedBlitz! This year's theme for Rare Disease Day continues off of last year's theme--research. According to RareDiseaseDay.org, patients are not only subjects but also proactive actors in research--and we couldn't agree more! Mark2Cure would not be where it is now without the inspiration, contributions, and drive from our partners and contributors in the rare disease community. Mark2Curators have inspired us with their generosity, perseverance, curiosity, and overall intellectual voraciousness--and for us, Rare Disease Day is an opportunity to share about the diseases that the Mark2Cure community cares about--and not just NGLY1-deficiency. If there is a disease that you care about that you'd like us to highlight for Rare Disease Day, please get in touch.

Patients are not only subjects but also proactive actors in research.
Patients kick start research
Patients drive research
Patients organize research
Patients proactively provide data

The increasing role of patients in research is not limited to Rare Disease
As citizen science becomes increasingly popular in biomedical research, patients and care providers are becoming increasingly important partners for disease research in general. And, as many of you have pointed out--we will all be patients at some point in our lives so it's nice to be able to actively contribute to disease research.

In addition to helping to organize the knowledge surrounding NGLY1-deficiency, patients and citizen scientists have been making important contributions to Alzheimer's disease research and contributing to health evidence--all of which brings us back to CitSciMed Blitz!

CitSciMed Blitz is coming

Similar to last year's MedLitBlitz, there will be prizes for the top contributors to all THREE platforms. Only participation during the 24hr challenges will count towards the prize, however, you are welcome to register and complete the training for the other platforms prior to the event if you'd like. Learn more about the event and the other platforms here.